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Abstract.  
This paper studies the statistical analysis of COVID 19 in Erbil, Kurdistan region by 
considering multiple regression model. we present the details analysis of COVID 19 in 
Erbil, Kurdistan using statistical model (multiple regression analysis). The regression 
model is used to predict the recovery cases of COVID 19 in Erbil, Kurdistan. Based on 
our findings from the regression model, we observed a significant difference in the 
regression coefficient of the model. Also, the higher the number of test patient leads to the 
higher number of recovery patient, moreover, there is a lesser effect in the recovery rate 
compared with the fatality cases. Lastly, we came up with some suggestions that will curb 
the spreading of COVID 19, increase the number of recovery cases, control the higher 





It was on Thursday morning, 24 February 2020, in Iraq, everybody was busy with their daily routine, when 
the Ministry of Health confirmed the first positive case of COVID 19 disease that was known for other 
countries now has become true and real in Iraq. The first confirmed patient was someone who came back 
from abroad to Iraq. The patient shows some symptoms of COVID 19 on February 24. From February 24 
to March 30, 2020, the Ministry of Health declared by the President of Iraq announced a country-wide 
lockdown taking effect on 14 March 2020. The rapid spreading of COVID 19 has raised the total number 
of confirmed cases to 234934, of which 176602 have recovered and 7042 have died by the end of August 
2020. The cases were increased day by day. To date, Iraq has officially confirmed to have high level cases, 
with 1.4 million active confirmed cases, 1.31 million recovered, and 17, 548 deaths due to COVID 19. As 
the virologists are focusing their attention on developing a vaccine, mathematicians rely on modeling 
techniques to produce multi-scenario models that could be utilized to foresee the future, see [1]. Multiple 
regression generally explains the relationship between multiple independent or predictor variables and one 
dependent in [2]. The authors in [3] studied the modeling fatality rate of COVID – 19 in Nigeria using 
multiple linear regression analysis. General guide associated with COVID 19 is given [4] while the obtained 
data and some useful information regarding this research was extracted from [5]. Some mathematical 
preliminaries were obtained from [6, 7]. 
 
The main aim of this paper is to develop a regression analysis model that will study the recovery 
cases of COVID 19 in Kurdistan region, we obtained the data  regarding COVID 19 from 
https://gov.krd/coronavirus-en/dashboard/ and analysis/model the data using regression analysis. The 
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regression model is used to predict the recovery cases of COVID 19 in Erbil, Kurdistan region. Based on 
our findings from the regression model, we will come up with some suggestions that will curb the spreading 
of COVID 19, increase the number of recovery cases, control the higher number of death cases, and 
prevent the future occurrence of COVID 19 in Erbil, Kurdistan region.  The paper is arranged as follows: 
Section 2 briefly explain mathematical preliminaries and statistical terms. Section 3 present the data 
collection and statistical analysis of COVID 19 in Erbil, Kurdistan region. method, results, and discussion 
are provided in Section 4. And conclusion is given in Section 5. 
 
2. Mathematical Preliminaries and Statistical Definition  
 
i. The arithmetic mean can be computed as an arithmetic formula is a group of numbers with a 
common difference. Arithmetic formulas are sometimes called arithmetic series or arithmetic 
sequences. This lesson will define an arithmetic formula and give some examples. 






ii. Geometric in Math means the average of which indicates the typical value of a set of numbers by 
using the product of their values (as opposed to the arithmetic mean, which uses their sum). The 
geometric is defined as the nth root of the product of n numbers, i.e., for a set of numbers x1, x2, 
..., xn 





iii.  The harmonic: -could be such a mathematical typical. It is determined by isolating the quantity of 
perceptions by the correlative of each number inside the plan. Along these lines, the consonant 
brutal is the relating of the calculating merciless of the reciprocals. 










iv. A standard deviation is a measurement that actions the scattering of a dataset comparative with its 
mean and is determined as the square base of the change.  




v. Skewness refers to a contortion or unevenness that goes amiss from the balanced ringer bend, or 
typical dispersion, in a bunch of information. On the off chance that the bend is moved to one side 
or to one side, it is supposed to be slanted. Skewness can be evaluated as a portrayal of the degree 
to which a given dissemination shifts from a typical appropriation. A typical conveyance has a slant 
of nothing, while a lognormal appropriation, for instance, would show some level of right-slant. 











vi. The term variance refers to a factual estimation of the spread between numbers in an informational 
index. More explicitly, fluctuation estimates how far each number in the set is from the mean and 
along these lines from each and every other number in the set. Difference is regularly portrayed by 
this image: σ2. It is utilized by the two investigators and brokers to decide instability and market 
security. The square foundation of the difference is the standard deviation (σ), which decides the 
consistency of a venture's profits throughout some stretch of time. 
      The formula of the variance is = 
1
n
 ∑ (x − x̅)2ni=1  
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vii. Covariance measures the directional connection between the profits on two resources. A positive 
covariance implies that resource returns move together while a negative covariance implies, they 
move contrarily. 




viii.  Pearson’s correlation (also called Pearson’s R) is a relationship coefficient regularly utilized in 
direct relapse. In case you are beginning in measurements, you will presumably find out about 
Pearson's R first. Indeed, when anybody alludes to the connection coefficient, they are generally 









3.  Data Collection and Statistical Analysis of COVID 19 in Kurdistan  
 
This section presents the data collected regarding COVID 19 from Erbil hospital for the months of October 
2020, November 2020, and December 2020. The data constitutes the test results, positive results, recovery 
results, and dead results. The collected data are used to interpret and illustrate the histogram. pie chart, and 
line chart for the test results, positive results, recovery results, and dead results. The collected data and the 
histogram. pie chart, and line chart for the test results, positive results, recovery results, and dead results 
are respectively presented in the table and figures below. 
 
Table 1: Daily data of patient for the months of October, November, and December 2020. 
 
The data of October 2020.         The data of November 2020.      The data of December 2020. 
Day test positive recover dead Day test positive recover dead Day  test positive recover Dead 
1 1792 229 186 2 1 2176 398 119 5 1 1307 91 117 5 
2 1640 192 187 2 2 2522 524 116 7 2 1390 91 119 5 
3 841 103 158 3 3 2404 453 114 7 3 1532 97 107 4 
4 2182 276 119 2 4 2378 392 115 5 4 692 78 103 2 
5 1867 337 118 7 5 2396 433 124 5 5 1401 17 116 4 
6 1591 297 104 4 6 2073 342 104 7 6 1548 65 113 3 
7 2233 358 93 2 7 1331 241 123 4 7 1266 110 105 2 
8 2153 281 105 4 8 1938 296 118 6 8 1099 89 115 2 
9 1633 206 106 1 9 2078 303 106 2 9 1021 64 113 3 
10 1467 217 134 3 10 2043 346 95 6 10 905 53 116 3 
11 1774 233 110 6 11 828 77 94 3 11 126 41 117 2 
12 2023 291 106 2 12 3298 489 106 3 12 1414 4 101 3 
13 1917 317 104 4 13 2034 193 110 10 13 818 52 105 3 
14 1914 235 115 5 14 1497 161 109 7 14 986 54 114 1 
15 2035 322 136 10 15 2144 231 103 5 15 1856 43 119 0 
16 2227 275 116 5 16 2495 223 112 4 16 1860 44 118 0 
17 1170 156 117 3 17 1687 156 105 9 17 1514 35 122 2 
18 2021 274 126 8 18 2143 193 115 5 18 662 47 114 2 
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19 2102 326 114 6 19 2111 154 121 3 19 2040 3 108 0 
20 1937 305 119 6 20 1992 188 105 8 20 1667 32 163 1 
21 2594 422 143 5 21 1506 66 104 4 21 1558 44 176 1 
22 2192 424 167 2 22 2636 193 116 3 22 1822 35 156 2 
23 2289 461 134 4 23 1638 152 114 6 23 1550 37 134 1 
24 1402 330 133 4 24 1668 135 115 5 24 1321 29 124 0 
25 2141 331 128 8 25 1416 144 117 3 25 1730 30 134 0 
26 2141 486 146 6 26 1905 123 117 2 26 977 14 122 2 
27 2711 703 105 2 27 1292 105 128 7 27 1730 39 113 1 
28 2718 596 117 6 28 827 39 102 4 28 977 22 121 1 
29 2717 580 114 2 29 1237 98 119 3 29 1111 19 102 0 
30 2250 424 105 7 30 1437 111 114 1 30 851 16 108 1 
31 1310 214 117 5      31 1043 41 233 0 
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 Figure 3.2: Pie chart of test result for the months of October, November, and December. 
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Figure 3.4: Histogram of positive result for the months of October, November, and December. 
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Figure 3.6: Line chart of positive result for the months of October, November, and December 
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Figure 3.8: Pie chart of recover result for the months of October, November, and December. 
 
 
Figure 3.9: Line chart of recover result for the months of October, November, and December. 
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Figure 3.10: Histogram of dead result for the months of October, November, and December. 
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Figure 3.12: Line chart of dead result for the months of October, November, and December. 
 
4. Method, Results and Discussion.  
 
The main aim of this section is to provide the multiple linear regression analysis and results in details of 
the collected data from Erbil, Kurdistan region. The multiple linear regression analysis is used to 
investigates the recovery cases of COVID 19 in Erbil, Kurdistan region. The main goal is to come up with 
an estimate outcome supporting the set of variables. This case can be achieved by using the multiple linear 
regression analysis to find a prediction model. We want to obtain a model that fits best of the given data 
and demonstrate the response variable. Moreover, the model can be used to correlate the independent 
variables, transformation, and interaction. We are going to consider the R square ability to investigate the 
best model. 
Consider the simple linear regression model as 
 
yi = β0 + β1xi + ei, 
 
where β0, β1 are the unknown constants of linear regression, xi are the independent variables, y is the 
dependent variable and ei is the error terms in the given data. Regarding our work, we consider the 
following multiple linear regression model. 
 
yi = β0 + β1xi1 + β2xi2 + β3xi3 + ei, 
 
where β0, β1, β2, and β3 are the unknown coefficients of the multiple linear regression, the independent 
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which correspond to the dependent variable and ei is the error terms in the given data. 
 
Table 4.1: Descriptive Statistics of COVID 19. 
Vari 









y 92 146.40 8.20 53.73 32.00 74.25 122.00 216.50 315.00 93, 122 3 
x1 92 1202.6 42.6 34.00 305.0 842.3 1220.5 1546.8 1932.0 1080,1175, 
1740, 1912 
2 
x2 92 181.61 9.72 51.32 24.00 104.50 192.00 228.25 442.00 73 3 
x3 92 5.967 0.385 61.93 0.000 3.000 6.000 8.000 15.000 4 14 
  
Table 4.2: Method and Correlations 
Method 
Correlation type Pearson 
 Rows used 92            
  
Correlations 
  y x1 x2 
x1 0.585     
x2 0.285 0.682   
x3 0.389 0.419 0.460 
 
A multiple linear regression analysis was employed to investigates the recovery cases of COVID 19 in 
Erbil, Kurdistan region. The cumulative number of COVID 19 test cases ( 
x1), the confirmed positive cases (x2), and the dead cases (x3) are treated as the independent variables 
while the total number of recovery cases (y) was treated as the dependent variable. The results obtained 
that guaranty the model that best fits the data is presented in table 4.3. 
 
Table 4.3: Regression Analysis for 𝐲 versus 𝐱𝟏, 𝐱𝟐, 𝐱𝟑. 
Term Coefficients  Std Error T-Value P-Value VIF 
Constant 2.6 20.2 0.13 0.899   
β1 0.1318 0.0218 6.04 0.000 1.92 
β2 -0.2456 0.0980 -2.51 0.014 2.01 
β3 5.02 1.99 2.52 0.013 1.30 
 
The model is given as 
 
Total number of recovery cases = 2.6 + 0.1318Test Cases - 0.2456Positive Cases +5.02Dead Cases 
 
The model recommends that to any unit increment in test cases of coronavirus, there will be 0.1318 
increment in the number of recovery cases, observe that the P-value is 0.000, this indicates that the 
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regression coefficient is significant to the fitted model. Also, to any every unit decrement in positive cases 
of coronavirus, there will be 0.2456 decrement in the number of recovery cases, observe that the P-value is 
0.014, this indicates that the regression coefficient is significant to the fitted model. Moreover, for any unit 
increment in dead cases of coronavirus, there will be 5.02 increment in the number of recovery cases, 
observe that the P-value is 0.013, this indicates that the regression coefficient is significant to the fitted 
model. Furthermore, the constant 2.6 indicate an increment in the recovery cases which is due to obeying 
the rules and regulations surrounding the quarantine and self-isolation. 
 
Table: 4.4: Model Summary 
S R-sq R-sq(adj) R-sq(pred) 
61.4472 40.99% 38.97% 36.21% 
  
The R-square is 0.62. 










Table 4.6: Fits and Diagnostics for Unusual Observations 
Obs y Fit  Resid    Std Resid     
43 93.0 94.5 -1.5 -0.03   X 
57 280.0 137.1 142.9 2.36 R   
58 296.0 157.9 138.1 2.29 R   
83 315.0 166.5 148.5 2.45 R   
 
R means large residual and X means unusual. 
The overall significant indicates that there is significant difference in the regression coefficients of the 
model as shown in table 4.5. Which shows that the regression model best fit for the data. 
 
Model DF  Adj SS Adj MS F-Value P-Value 
Regression 3 230767 76922 20.37 0.000 
         β1 1 137653 137653 36.46 0.000 
β2 1 23735 23735 6.29 0.014 
       β3 1 24030 24030 6.36 0.013 
Error 88 332267 3776     
Total 91 563034       
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Figure 4.1: Pearson Correlation Plot for y, x1, x2, x3, 




This paper model the recovery cases of COVID 19 in Erbil, Kurdistan region using multiple regression 
analysis. Based on the estimated model outcomes, we observed that, the higher the number of test patient 
leads to the higher number of recovery patient, moreover, there is a lesser effect in the recovery rate 
compared with the fatality cases. Among the few problems that leads to the higher rate of the fatality rates 
are the patients with underlined health challenges associated with COVID 19, COVID 19 patients with age 
above sixty years and the health personal which are in the front line. Our suggestions are, more attention 
and precautions should be given to the front-line health personal, covid patient with age above 60, patients 
with underlined health challenges associated with COVID 19 and lastly, government should make sure they 
imposed all the necessary action that will make everybody obeys the rules and regulations surrounding the 
quarantine, self-isolation and COVID 19 in general. Perhaps this may reduce the number of positive cases, 
the number of death cases, and increase the number of recovery cases. 
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